Skip to content

Effects of Music Intervention Combined With Progressive Muscle Relaxation in Cancer Patients

Effects of Music Intervention Combined With Progressive Muscle Relaxation on Anxiety, Depression and Quality of Life in Breast and Gynaecological Cancer Patients Receiving Chemotherapy: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05262621
Enrollment
84
Registered
2022-03-02
Start date
2022-03-08
Completion date
2022-08-10
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

music intervention, progressive muscle relaxation, anxiety, depression, quality of life, chemotherapy, beast cancer, gynaecology cancer

Brief summary

Study design A 2-arm, assessor-blinded randomised controlled trial will be conducted. The design will follow the Standard Protocol Items Recommendations for Interventional Trials (SPIRIT)

Detailed description

Aim: To assess the effect of MCP on anxiety, depression and QoL of BGC patients receiving chemotherapy. Objectives * To assess the effect of MCP on the anxiety of BGC patients receiving chemotherapy. * To assess the effect of MCP on depression of BGC patients receiving chemotherapy. * To assess the effect of MCP on QoL and patients' satisfaction of BGC patients receiving chemotherapy. * To determine whether stress level, coping and coping styles mediate the intervention effect on anxiety, depression and QoL. Hypothesis * The participants receiving MCP will have a significantly lower level of anxiety compared to the control group. * The participants receiving MCP will have a significantly lower level of depression compared to the control group. * The participants receiving MCP will have significantly higher QoL scores and levels of satisfaction with care service compared to the control group. * Stress level, coping will mediate the intervention on target outcomes.

Interventions

OTHERprogressive muscle relaxation

Practice muscle relaxation for 20 minutes once/a day

OTHERListening to relaxing music once/day

Right after practising progressive muscle relaxation, the participants will listen to relaxing music for 20 minutes

Sponsors

The Nethersole School of Nursing
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

The research assistants who assess outcome data, data entry and analysis will be blinded to avoid the risk of assessor bias. The assistants will not participate in any other stage of implementing the program.

Intervention model description

Parallel Assignment

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women with breast or gynaecological cancer are 18 years of age or older, and are independent legally to sign the consent form. * Living with family and having an adult family member agree to participate in the meeting part of the program. * Had been informed the cancer diagnosis * Have Karnofsky score (Mor et al., 1984) ≥ 80 ( to be able to self-practice MCP) * Can communicate, read and write in Vietnamese * Have a device such as a smartphone, MP3 to keep the audio file (to self-practice MCP at home) * Consent to join the study

Exclusion criteria

* The patients cannot understand the study procedures * Have mental health illness, deafness, blindness * Have not been aware of their cancer or the purpose of chemotherapy * Be participating in other studies related to psychological issues * Be receiving anxiety or depression treatment. * Be participating in relaxation therapy such as yoga, meditation, mindfulness, PMR... * Have a potential treatment (eg. surgery) or personal plans that will prevent them from practising daily during the 6 weeks of the intervention.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline anxiety at 3 weeks and 6 weeksebaseline, T1 after 3 weeks, T2 after 6 weeksit will be measured using the short form of the Depression Anxiety Stress Scale (DASS-21). It includes 7 items for anxiety (DASS21-A). A 4-point Likert-type scale ranging from 0 to 3 was designed for each item, and the scores will need to be multiplied by 2 to calculate the final score. Thus, the anxiety score can range from 0 to 42. The higher the score is the more severe anxiety. The score of 0-7 is normal, 8-9 mild, 10-14 moderate, 15-19 severe, +20 extremely severe.
Change from baseline depression at 3 weeks and 6 weeksbaseline, T1 after 3 weeks, T2 after 6 weeksit will be measured using the short form of the Depression Anxiety Stress Scale (DASS-21). It includes 7 items for depression (DASS21-D). A 4-point Likert-type scale ranging from 0 to 3 was designed on each item, and the scores will need to be multiplied by 2 to calculate the final score. Thus, the depression score can range from 0 to 42. The higher the score is the more severe depression. The score of 0-9 is normal, 10-13 mild, 14-20 moderate, 21-27 severe, +28 extremely severe.

Secondary

MeasureTime frameDescription
Change from baseline stress at 3 weeks and 6 weeksbaseline, T1 after 3 weeks, T2 after 6 weeksit will be measured using the short form of the Depression Anxiety Stress Scale (DASS-21). It includes 7 items for stress (DASS21-S). A 4-point Likert-type scale ranging from 0 to 3 was designed for each item, and the scores will need to be multiplied by 2 to calculate the final score. Thus, the stress score can range from 0 to 42. The higher the score is the more severe stress. The score of 0-14 is normal, 15-18 mild, 19-25 moderate, 26-33 severe, +34 extremely severe.
Change from baseline coping styles at 3 weeks and 6 weeksbaseline, T1 after 3 weeks, T2 after 6 weeksCoping will be measured using Brief COPE. The Brief-COPE is a 28 item self-report questionnaire designed to measure effective and ineffective ways to cope with a stressful life event.The scale can determine someone's primary coping styles with scores on the following three subscale: Problem-Focussed Coping, Emotion-Focussed Coping, Avoidant Coping.A 4-point Likert-type scale ranging from 1 to 4 was designed on each item.
Change from baseline quality of life at 3 weeks and 6 weeksbaseline, T1 after 3 weeks, T2 after 6 weekscoping will be measured using FACT-G.It evaluates in functional scales on Social/family well-being (SWB); Emotional well-being (EWB) and Functional well-being (FWB). Each item is scored in one of five categories of 0-4, with 'Not at all', 'A little bit', 'some what', 'Quite a bit' 'Very much'. The higher the score is the better quality of life. The possible range of scores is from 0 to 112.
Change from baseline satisfaction of nursing care at 3 weeksbaseline, T1 after 3 weeks,satisfaction of nursing care will be measured using numerical rating scale.(0-10) from 0 = completely dissatisfied with the care to 10 = completely satisfied with the care.

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026